Clinical Trials on Advanced Solid Cancers Refractory to PD-1
Total 842 results
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Immunotherapy | Anti-PD-1 Antibody | Persistent Advanced Cervical CarcinomaChina
-
Samsung Medical CenterActive, not recruitingAdvanced, Refractory CancerKorea, Republic of
-
GlycoNex, Inc.TerminatedSolid Tumor | Metastatic Cancer | Advanced Cancer | Unresectable Solid NeoplasmUnited States, Taiwan
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Deciphera Pharmaceuticals LLCTerminatedMetastatic Solid Tumors | Locally Advanced Tumors | Cancers With MET Genomic Alterations | Cancers With TRK Genomic AlterationsUnited States
-
Shanghai Zhongshan HospitalActive, not recruitingBiliary Tract Cancer | PD-1 Antibody | Lenvatinib | GemoxChina
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Tachyon Therapeutics, Inc.RecruitingSolid Tumor | Metastatic Solid Tumor | Advanced CancerUnited States
-
EpicentRx, Inc.TerminatedMetastatic Cancer | Advanced Cancer | Malignant Solid TumorUnited States
-
Immatics Biotechnologies GmbHRecruitingCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerGermany
-
Immatics US, Inc.CompletedCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerUnited States, Germany
-
Beijing Friendship HospitalCompletedCamrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.Biliary Tract Cancer | Capecitabine | Targeted Molecular Therapy | Anti-PD-1 TherapyChina
-
Genentech, Inc.RecruitingSolid Tumor, Adult | Refractory Cancer | Recurrent CancerAustralia
-
Sun Yat-sen UniversityRecruitingImmunotherapy | DMMR Colorectal Cancer | Anti PD-1China
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Relapsed/Refractory LymphomaUnited States
-
Deciphera Pharmaceuticals LLCRecruitingNon-Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid TumorUnited States
-
Washington University School of MedicineMerck Sharp & Dohme LLC; The Foundation for Barnes-Jewish Hospital; Verastem,...CompletedPancreatic Cancer | Advanced Solid Tumors | Solid TumorsUnited States
-
Merck Sharp & Dohme LLCTerminatedBreast Cancer | Advanced Solid Tumors
-
Immatics US, Inc.CompletedNeoplasms | Adult Solid Tumor | Refractory Cancer | Recurrent CancerUnited States
-
Fudan UniversityNot yet recruitingthe Efficacy and Safety of PD-1 Inhibitors With or Without Radiotherapy in Patients With Advanced MelanomaChina
-
Immatics Biotechnologies GmbHBristol-Myers SquibbRecruitingCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerGermany
-
Washington University School of MedicineAclaris Therapeutics, Inc.WithdrawnAdvanced Solid Tumor | Advanced Solid Tumor MalignanciesUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Auransa, Inc.RecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Advanced Hepatocellular Carcinoma | Metastatic Malignant Neoplasm in the Liver | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Advanced CholangiocarcinomaUnited States
-
Philogen S.p.A.CompletedAdvanced Solid Tumors Amenable to Anthracycline Therapy | Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline TherapyGermany, Italy
-
Daiichi SankyoAstraZenecaRecruitingBreast Cancer | Advanced Solid TumorUnited States, Spain, Canada, France
-
Sunshine Lake Pharma Co., Ltd.Not yet recruitingEsophageal Cancer | Advanced Solid TumorChina
-
AbbVieActive, not recruitingAdvanced Solid Tumors CancerUnited States, Australia, Canada, France, Japan, Korea, Republic of, Spain
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Relapsed/Refractory LymphomaUnited States
-
Lantern Pharma Inc.RecruitingAdvanced Solid Tumor | Relapsed or Refractory LymphomasUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Excluding Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerNetherlands, Switzerland, Denmark, United States
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, Spain, France, Italy, Korea, Republic of, Poland
-
Fudan UniversityNot yet recruitingGastric Cancer | MSI-H | Adjuvant Therapy | PD-1 ImmunotherapyChina
-
Cornerstone PharmaceuticalsCompletedLymphoma | Metastatic Cancer | Advanced Cancer | Solid Tumors | Advanced MalignanciesUnited States, Canada
-
ImmunityBio, Inc.Active, not recruitingSolid Tumor | Metastatic Cancer | Locally Advanced Solid TumorUnited States
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
Hoffmann-La RocheCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Korea, Republic of
-
University of Colorado, DenverCancer League of ColoradoWithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | PD-L1 Gene MutationUnited States
-
Xuanwu Hospital, BeijingUnknownNon-small Cell Lung Cancer | PD-1 Antibody | Lung Cancer Stage II
-
M.D. Anderson Cancer CenterNational Comprehensive Cancer NetworkCompletedSolid Tumors | Liver Cancer | Advanced CancersUnited States
-
Daiichi Sankyo, Inc.CompletedAdvanced Solid Malignant Tumors | Advanced Ovarian CancerUnited States
-
St. Jude Children's Research HospitalRecruitingHepatocellular Carcinoma | Pediatric Cancer | Malignant Solid Tumor | Fibrolamellar Carcinoma | Pediatric Solid Tumor | Refractory Solid TumorUnited States
-
AbbVieCompletedAdvanced Solid Tumors CancerUnited States, Australia, Israel
-
M.D. Anderson Cancer CenterIndena S.p.AActive, not recruiting
-
National Cancer Institute (NCI)CompletedAdvanced Breast Cancer | Advanced Solid Tumors | Primary Peritoneal Cancer | Advanced Ovarian CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingChemotherapy Effect | Lung Cancer Stage IV | PD-1 Antibody | Lung Cancer Squamous CellChina
-
Taiho Oncology, Inc.CompletedAdvanced Solid Tumors (Excluding Breast Cancer)United States